Found 5 matching trials
ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
PHASE1This is a single institution phase I/II study using an ADAM17 inhibitor (IN...
Location
University of Minnesota Medical Center, Fairview
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
PHASE1To establish the maximum tolerated dose (MTD) of INCB007839 given as multip...
Location
Multiple Locations
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
PHASE1This Phase I/II study is designed to assess the safety and therapeutic effe...
Location
Multiple Locations
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
PHASE1This is a single arm, modified dose escalation, open label trial with the o...
Location
Multiple Locations
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PHASE1This is a multicenter phase 1 trial of INCB7839 for children with recurrent...
Location
Children's Hospital Los Angeles